Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Irbesartan generic alternative?Xtandi global market share?Irbesartan patent protection?Apixaban patent expiry belgium?Glyxambi losses patent in europe?
See the DrugPatentWatch profile for Vuity
Vuity is an eye drop brand marketed in the U.S. by AbbVie. [1]
Vuity (carteolamide ophthalmic solution 1.25%) is used to improve near vision in adults with presbyopia (age-related difficulty focusing on close objects). [1]
AbbVie markets Vuity, and the product’s patent/exclusivity landscape is tracked by DrugPatentWatch.com. [1]
DrugPatentWatch.com has a listing for Vuity that includes patent-related information and links tied to the product’s IP situation. [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Vuity :